‘Aids vaccine already exists’
By Faiza Ilyas
KARACHI: In view of the difficulties and high costs involved in different drug treatments, preventing the HIV infection has been the major focus of research in combating Aids.
A vaccine, it has been assumed, would probably cost less, thus being affordable by developing countries, bearing a major burden of the deadly disease.
Though many claims have been made, a vaccine for Aids still seems to be a distant dream even after decades of research.
One of the few Pakistani scientists working on this difficult task is Dr Omar Bagasra, an eminent immunologist, molecular biologist and retro-virologist working in the US.
A recipient of numerous awards, Dr Bagasra is currently the director of Claflin University’s South Carolina Centre for Biotechnology and a diplomat of the American Board of Medical Laboratory Immunology and the American boards of Forensic Examiners and Forensic Medicine. In 1995, he was also nominated for the King Faisal Award for Medicine.
One of his major contributions is the invention of in-situ PCR (Polymerase Chain Reaction) technique, enabling single copies of a gene to be amplified inside a cell.
Dr Bagasra’s research interests have long been associated with the study of HIV and Aids. In fact, he has been on the trail of the virus since 1981.
Recently, he was in the city and gave presentations at a few universities.
Talking to Dawn about his work on the development of a vaccine for HIV/Aids, he said that it was a brand new concept in vaccination. “We think we have a way to stop HIV. In my laboratory we have discovered some genes, which, if injected into a human body, immunises a person against HIV. That means an Aids vaccine already exists.”
Elaborating upon this, he said that as part of his work he experimented with different blood samples.
“I tested the blood samples of 120 people; infecting the same amount of virus in a sequence. But, there was no development of HIV in some blood samples no matter what you do. This made us realise that there are some people who are naturally immune to HIV.”
These findings led him to write the book, HIV and Molecular Immunity: Prospects for the Aids vaccine, in the 1990s.
He further says that a virus similar to HIV called the Simian immunodeficiency virus (SIV) is present among 40 species of primates, but they do not develop HIV. “They must have these genes. A fraction of the human population also has this RNA-based protected mechanism against HIV/Aids. Nobody has ever immunised with the RNA in history. So it would be the next big thing. The RNA-based vaccine would also help treat those infected with HIV.”
When asked about the time for the availability of the vaccine, he said: “The US has very stringent laws for testing drugs and vaccines. The process can take another 10 years in this case, but I plan to seek help from my friend, Dr Luc Montagnier, a French virologist who won the 2008 Nobel Prize in physiology for his discovery of human immunodeficiency virus (HIV) in this regard. I feel that the vaccine does not need to be tested on animals and can directly be used on humans.
“However, this has to be pre-approved by the US Food and Drug Administration and the Institutional Review Board before we can take such a step. Even then it will take 5-6 years to confirm that the protective micro-RNA can be useful,” he was quick to add.
Referring to the difficulties scientists have been facing in the development of an Aids vaccine, he said that the process was complicated. Earlier, people used protein-based vaccines for HIV/Aids. But, the results had been very discouraging, as it was observed that people who were vaccinated died first. “This was because people get Aids faster if the immune system has been stimulated.”
Dr Bagasra is also working on an oral vaccine for malaria using transgenic tomatoes to carry different antigens. “After resolving some technical issues, the tomatoes will be tested on humans. Since antigens have to be in the seeds, so initially it will be a costly affair. However, poor countries won’t have to bear the cost, as we plan to seek the World Health Organisation’s help in this regard.”
Giving some insights into crime scene investigation, Dr Bagasra said DNA profiling had revolutionised forensic science.
“Every human being sheds 10 per cent of his or her skin every day. If a crime scene is not disturbed and investigators reach the site quickly, the identity of the individuals at the time of the crime can be ascertained by a filter that collects the skin particles left there. But, for that you need to get a DNA reference sample to match the evidence taken from the scene,” he said.
However, this helpful gadget did not undermine the significance of conducting a proper investigation and collecting other evidences from the crime scene. And, in fact, 90 per cent of crime cases were resolved without resorting to DNA testing in the US, he added.


